European Commission Agrees COVID-19 Vaccine Deal With CureVac

The European Commission has signed a COVID-19 vaccine contract with German biopharmaceutical company CureVac, President Ursula von der Leyen announced Monday.

“Today we signed our 5th vaccine contract, with CureVac,” von der Leyen tweeted from her official account.

She said the European Commission has now secured almost 2 billion doses of potential coronavirus vaccines and that Europeans would have access to them once they are approved as safe and effective, “hopefully before the end of the year!”

EU Health Commissioner Stella Kyriakides said on Twitter that the deal put European and global citizens and economies another “step closer to delivering a safe and sustainable exit strategy from the crisis.”

And 5 ✅!

Today we signed our 5th vaccine contract, with @CureVacRNA

Overall we have secured almost 2 billion doses of future #COVID19 vaccines.

Europeans will be able to get them, once they have proven to be safe & effective – hopefully before the end of the year! https://t.co/aNOEE2LVzS

— Ursula von der Leyen (@vonderleyen) November 30, 2020